AzTrials
AzTrials

Practice Nurse's ScopePROPAGE2NCT04818684

Practices of Accompaniment of the Relatives of Patients in the AGonic Phase by an Interdisciplinary Team

An observational study of Practice Nurse's Scope, run by University Hospital, Bordeaux at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The PROPAGE study program aims above all to improve the experience and satisfaction of family and friends regarding the support they receive during the dying person's agony phase. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Practice Nurse's Scope
What is being tested?
questionnaire
How many people
278 participants
Where
1 siteFrance
Study dates
1 Dec 2021to 15 May 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: This includes people working in a palliative care unit as well as relatives who have known a patient in agony phase in a palliative care unit.

Who may be able to join

  • PALLIATIVE CARE UNITS (USP) 35 palliative care unit will be drawn at random among the 164 French palliative care unit (www.sfap.org). In the event of refusal of participation, the drawing of lots will continue until 35 participating palliative care unit are obtained. The inclusion criteria for palliative care units were determined from the survey carried out in 2013 by the National End of Life Observatory on palliative care units in France. In order for there to be representativeness, the status of the palliative care unit will be taken into account from the national University Hospital (CHU) distribution, excluding CHU in the public sector, private non-profit sector, private for-profit sector. Thus, out of the 35 palliative care units: 7 will be within CHU, 16 will be outside CHU in the public sector, 7 will be in the private non-profit sector, and 5 in the private for-profit sector (criteria determined from the survey of the National End of Life Observatory in 2013) by ensuring that there are no more than 3 palliative care units in the same department (this in order to avoid that a geographical territory is over-represented, which would be liable to bias the results).
  • In the event of refusal of a palliative care units or of inadequacy of the criteria, the drawing of lots will be continued until 35 participating USPs are obtained.
  • Each team of these palliative care units must allow the participation of 7 experts: 1 for each group of experts, i.e. 5 socio-health professionals working in all the palliative care units (doctors, psychologists, nursing assistants, nurses, socio-educational assistant) as well as the coordinator of support volunteers and a relative by palliative care unit.
  • THE EXPERTS
  • 6 volunteer experts who will participate in the panel of voters: a doctor (group 1), an IDE ( group 2), an AS (group 3), a psychologist (group 4), an ASE (group 5), a volunteer support coordinator (group 6) . A relative (group 7) will be done.
  • The inclusion criteria:
Show all 19Show fewer
  • For professionals, at least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
  • For volunteers, at least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit. The representative participating in the study will preferably be the volunteer coordinator.
  • For relatives Relative of a patient who died in the palliative care unit at least 6 months ago Person to trust or to prevent if not designated Relative understanding and speaking sufficient French Relative not a health professional
  • Relative who visited the palliative care unit during the last 3 days of the patient's life and who met the care team:
  • Traceability of the arrival of the loved one in the last 2/3 days of the patient's hospitalization
  • Traceability of a meeting of the loved one with a member of the team over the last 3 days of his hospitalization or verification during telephone contact with the loved one after drawing lots Relative with an email address (to be verified during telephone contact with the loved one after drawing lots)
  • NO-INCLUSION AND EXCLUSION CRITERIA
  • PALLIATIVE CARE UNITS Palliative care unit who could not be represented by the 7 experts required
  • Have participated in the PROPAGE 1 study
  • Have taken part in the questionnaire test.
  • THE EXPERTS Palliative care unit Experts: Anyone with less than 3 years of palliative care unit experience.
  • Relatives:
  • Relative of a patient who died in the palliative care unit less than 6 months ago Relative not understanding and not speaking French enough Relative being a health professional Relative who has not been to the palliative care unit in the last 3 days of the patient's life Relative who does not have an email address (to be checked during telephone contact with the loved one after drawing lots).

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu de Nimes

    Nîmes

Other trials in France

About this study

Official title: Practices of Accompaniment of the Relatives of Patients in the Agonic Phase by an Interdisciplinary Team

The PROPAGE study program aims above all to improve the experience and satisfaction of family and friends regarding the support they receive during the dying person's agony phase.

Read the detailed description

The objective of PROPAGE 2 is to establish a consensus on the practices for accompanying relatives during the agonic phase in the context of hospitalization in the palliative care unit by an interdisciplinary team.

Being tested
questionnaire
Keywords
Practices, accompaniment, interdisciplinary, relatives, agonic phase

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • questionnaireOther

    a questionnaire consisting of a list of support practices

Study groups in NCT04818684
Study groupRoleWhat they receive
Physicianat least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
Receives: Other: questionnaire
Psychologistsat least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
Receives: Other: questionnaire
Caregiversat least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
Receives: Other: questionnaire
Nursesat least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
Receives: Other: questionnaire
Social and Educational Assistantsat least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
Receives: Other: questionnaire
Volunteersat least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit. The representative participating in the study will preferably be the volunteer coordinator.
Receives: Other: questionnaire
RelativesRelative of a patient who died in the palliative care unit at least 6 months ago Person to trust or to prevent if not designated Relative understanding and speaking sufficient French Relative not a health professional Relative who visited the palliative care unit during the last 3 days of the patient's life and who met the care team: * Traceability of the arrival of the loved one in the last 2/3 days of the patient's hospitalization * Traceability of a meeting of the loved one with a member of the team over the last 3 days of his hospitalization or verification during telephone contact with the loved one after drawing lots Relative with an email address (to be verified during telephone contact with the loved one after drawing lots)
Receives: Other: questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Score of Likert-type scales (rated between 0 and 9), best match what each participant think about support practices for relatives of persons in the agony phase : from 1 (strongly disagree) to 9 (strongly agree).

    It is based on a questionnaire made up of a list of support practices developed from the literature review and the list of practices identified through focus groups in the preliminary study PROPAGE 1. The responses are collected. on Likert-type scales reflecting the degree of agreement towards a proposition (rated between 0 and 9) and / or in the form of free comments.

    Measured: Day 1

  2. Score of Likert-type scales (rated between 0 and 9), best match what each participant think about support practices for relatives of persons in the agony phase : from 1 (strongly disagree) to 9 (strongly agree).

    It is based on a questionnaire made up of a list of support practices developed from the literature review and the list of practices identified through focus groups in the preliminary study PROPAGE 1. The responses are collected. on Likert-type scales reflecting the degree of agreement towards a proposition (rated between 0 and 9) and / or in the form of free comments.

    Measured: Month 2

  3. Score of Likert-type scales (rated between 0 and 9), best match what each participant think about support practices for relatives of persons in the agony phase : from 1 (strongly disagree) to 9 (strongly agree).

    It is based on a questionnaire made up of a list of support practices developed from the literature review and the list of practices identified through focus groups in the preliminary study PROPAGE 1. The responses are collected. on Likert-type scales reflecting the degree of agreement towards a proposition (rated between 0 and 9) and / or in the form of free comments.

    Measured: Month 4

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2021
  2. Study start1 Dec 2021
  3. Primary completion15 May 2022
  4. Study completion15 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
278 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04818684
Sponsor's protocol ID
CHUBX 2019/60
Acronym
PROPAGE2
Status last verified
Jan 2024
First submitted
25 Mar 2021
Last updated
17 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Practice Nurse's Scope, run by University Hospital, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 19 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Score of Likert-type scales (rated between 0 and 9), best match what each participant think about support practices for relatives of persons in the agony phase : from 1 (strongly disagree) to 9 (strongly agree). (time frame: Day 1). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in